StarLink corn recall
StarLink Corn Recall
The StarLink corn recall was a significant event in the early 2000s involving the withdrawal of food products containing genetically modified corn that had not been approved for human consumption. This incident highlighted the complexities and challenges associated with genetically modified organisms (GMOs) in the food supply chain.
Background
StarLink corn was a type of genetically modified corn developed by Aventis CropScience. It was engineered to express the Bacillus thuringiensis (Bt) Cry9C protein, which provides resistance to certain pests. However, due to concerns about potential allergenicity, the United States Environmental Protection Agency (EPA) approved StarLink corn only for animal feed and industrial use, not for human consumption.
Discovery and Recall
In September 2000, traces of StarLink corn were discovered in taco shells sold in grocery stores, prompting a nationwide recall. The discovery was made by a coalition of environmental and consumer advocacy groups who conducted independent testing. The presence of StarLink corn in human food products led to widespread concern and a series of recalls affecting numerous food products.
Impact
The recall had significant economic and regulatory impacts. It led to a loss of consumer confidence in the safety of the food supply and raised questions about the adequacy of regulatory oversight for GMOs. The incident also resulted in financial losses for farmers and food manufacturers, as well as increased scrutiny of biotechnology companies.
Regulatory Response
In response to the StarLink corn recall, the EPA and the Food and Drug Administration (FDA) took steps to improve the monitoring and regulation of genetically modified crops. This included more stringent testing and labeling requirements to prevent unauthorized GMOs from entering the human food supply.
Related Pages
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD